Postponed: Patient engagement in 2030: How can patient engagement contribute towards building a new ecosystem for drug development & therapy?

Samen met hollanbio


Patient engagement has become one of the key aspects in drug development and therapy during recent years and becomes more important as time progresses. At the same time, these processes are undergoing change towards a new ecosystem. By taking the lessons learned from the past, taking current initiatives and bright ideas for the future, patient engagement plays a crucial role in the future of drug development & therapy. Start your development with the end in mind!

In Q2 2022, exact date to be confirmed, admedicum Business for Patients will organize an event in collaboration with HollandBIO, where patient representatives will set the scene and subsequently multiple stakeholder speakers from healthcare, regulatory and industry will share constructive perspectives towards solutions, improvements and opportunities for patient engagement in 2030. The different perspectives will be followed by an interactive and open ‘parliamentary style’ debate.

Please click here for an overview of the exciting program with international speakers, including Nicola Bedlington (former Secretary General European Patient’ Forum), Cécile Olivier (C-Path), Ana Mingorance (Loulou Foundation), Joep Rijnierse (Amgen) and Annamarie Dillon (Orchard Therapeutics).

Practical info

  • Date: Q2 2022, exact date to be confirmed
  • Time: 14:00 doors open, 14:45 program, 17:30 drinks
  • Venue: Muntgebouw Utrecht, the Netherlands
  • Registration will be free


Unfortunately, we (admedicum) have to inform you that due to the recently announced additional rules by the Dutch Government to prevent the spread of COVID-19, it is currently not possible to continue our event on the scheduled date (2 December 2021). For us at admedicum, organizing a safe in-person event for all participants, including those that may be at higher risk for severe illness due to COVID-19, is for us our no. 1 priority. Also, we appreciate the need and desire of people to have fruitful exchanges / networking in a face-2-face environment, and we will therefore postpone the symposium to a new date as soon as this is possible again. We will also, from time to time, continue to share short insights to stimulate discussions around the topic of ‘Patient Engagement in 2030’.


Kaart wordt geladen...